Neurogene
NGNE
NGNE
63 hedge funds and large institutions have $21.4M invested in Neurogene in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less capital invested
Capital invested by funds: $49.7M → $21.4M (-$28.3M)
Holders
63
Holding in Top 10
–
Calls
$141K
Puts
–
Top Buyers
| 1 | +$907K | |
| 2 | +$356K | |
| 3 | +$219K | |
| 4 |
E
Ergoteles
New York
|
+$171K |
| 5 |
Two Sigma Advisers
New York
|
+$102K |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$1.7M | |
| 3 | -$476K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$292K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$252K |